Mon.Aug 19, 2024

article thumbnail

APhA Campaign Aims to Spread Awareness About Harmful PBM Practices

Drug Topics

The American Pharmacists Association is dedicating further time and resources to its ongoing fight for federal PBM reform.

220
220
article thumbnail

Analysis Finds Bidirectional Association Between Asthma and Psoriasis

Pharmacy Times

The study authors recommend that health care professionals are aware of the connections, notably in adolescent patients and those with moderate to severe psoriasis.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: Private equity: health care’s vampire

STAT

Private equity firms are sucking the resources out of America’s hospitals and nursing homes, and feeding on doctors to generate profits. These firms — which pool funds from wealthy investors and are exempt from many of the regulations and disclosure requirements that apply to other types of investments — have spent a half-trillion dollars since 2018 buying up medical resources.

article thumbnail

NACDS President Discusses Themes, Highlights of Total Store Expo

Pharmacy Times

Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.

139
139
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Study exposes the dangerous ‘hidden’ mental burden of cancer on patients’ spouses

STAT

The distress from receiving a cancer diagnosis is something that clinicians widely anticipate in patients, but suffering often doesn’t just afflict the patient. It can blanket an entire household, burdening spouses and other family members with stress and anxiety and the exhausting routine of treating a life-threatening disease. But while standards exist for assessing and managing distress in patients, it’s often “hidden” in family members, sometimes with devastating

145
145
article thumbnail

A Diabetes Intervention in Community Pharmacy Drives Value-Based Health Care

Drug Topics

A collaboration with Blue Cross and Blue Shield of North Carolina focused on commercial populations has improved care and lowered costs in the state.

More Trending

article thumbnail

US govt taps Walgreens for decentralised trials

pharmaphorum

Walgreens has signed a $100m contract with the US government's BARDA agency for access to its decentralised clinical trials network

133
133
article thumbnail

STAT+: Peter Orszag wants the FTC and DOJ to stop challenging health care mergers

STAT

Peter Orszag was instrumental in crafting the Affordable Care Act. Now, he wants federal antitrust authorities to ease up on their sharp scrutiny of health care transactions that he acknowledges the law has encouraged — and that make a lot of money for his investment bank. Orszag’s comments, made last week on TV, reveal how policymakers can end up profiting from the laws they help create.

Insurance 145
article thumbnail

First At-Home Syphilis Test Receives Marketing Authorization From the FDA

Pharmacy Times

The OTC antibody test can detect current or past infection but should be followed by additional testing to confirm diagnosis.

FDA 132
article thumbnail

Opinion: Graphic mpox images to educate the public are deeply problematic

STAT

For the second time in three years, the WHO has declared an mpox outbreak a public health emergency of international concern. Since news of the epidemic, the media has circulated images of patients infected with mpox. Some of these photographs show mpox on patients’ arms, legs, and hands, but others are headshots that resemble mugshots of African people with mpox covering their faces.

139
139
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Researchers Identify Predictors of Intravenous Immunoglobulin Resistance in Patients With Kawasaki Disease

Pharmacy Times

Noticing indicators of IVIG non-responsiveness can lead to better outcomes among patients with Kawasaki disease as treatment is adjusted.

123
123
article thumbnail

STAT+: Will the FTC challenge a deal that would give Novo Nordisk control of some Catalent plants?

STAT

As the Federal Trade Commission scrutinizes the pharmaceutical industry, there is growing debate about whether the regulator may next target a deal that some experts say could make it easier for Novo Nordisk to boost production of a key drug — at the expense of competitors. At issue is a complicated transaction sparked by sporadic shortages of one of the world’s hottest-selling medications — the weight loss treatment Wegovy.

117
117
article thumbnail

Pharmacy Forecast: GLP-1 Profitability Expected to Remain a Challenge

Drug Topics

Both the restructuring of direct and indirect remuneration fees and health care cyber attacks made an impact on the industry in the first half of 2024.

98
article thumbnail

STAT+: Another suit filed against FDA over lab-developed test rule

STAT

A group representing molecular pathologists sued the Food and Drug Administration on Monday over its plan to regulate lab-developed tests.  It’s the second legal challenge to the rule, following the American Clinical Laboratory Association’s suit in May. The suit, filed in Texas by the Association for Molecular Pathology and University of Texas pathologist Michael Laposata, claims that the FDA overstepped its regulatory bounds when deciding to regulate lab-developed tests.

FDA 114
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Online Resources Could Help Address Gaps in Pain Management

Drug Topics

Focus group participants were receptive to using eHealth tools, but noted several barriers such as cost and availability.

112
112
article thumbnail

FDA Grants Breakthrough Therapy Designation to DS-8201a and T-DXd to Treat Metastatic Breast Cancer

Pharmacy Times

Fam-trastuzumab deruxtecan-nxki has received 4 breakthrough therapy designations, including the latest approval.

FDA 123
article thumbnail

Genmab shuffles C-Suite on commercialization, manufacturing as portfolio grows

Fierce Pharma

Genmab is revamping its executive team as the Danish antibody specialist expands its commercialization efforts and looks to evolve into “a fully integrated biotech innovation powerhouse.” | Genmab is revamping its executive team as the Danish antibody specialist expands its commercialization efforts and looks to evolve into “a fully integrated biotech innovation powerhouse.

102
102
article thumbnail

Patient volumes have stormed back into hospitals

STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. A self-interested plea from Peter Orszag Peter Orszag, CEO of Lazard, went on CNBC last week and criticized how the Federal Trade Commission and Department of Justice were gumming up health care mergers.

Hospitals 104
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

FDA balks at standard approval of Liquidia's PAH rival to United's Tyvaso after lengthy court saga

Fierce Pharma

Liquidia and its dry powder Yutrepia is back in FDA limbo after the agency opted for a tentative approval as opposed to a standard nod. | The agency granted a broad regulatory exclusivity to rival United Therapeutics and its Tyvasvo DPI, leaving Liquidia's Yutrepia, which uses the same active drug, in FDA limbo until 2025.

FDA 102
article thumbnail

Safe Opioid Prescribing, Storage Are Crucial

Pharmacy Times

Pharmacists should educate patients about proper medication storage and offer naloxone to optimize safety.

169
169
article thumbnail

Were industry watchers too optimistic after IRA's price cut reveal? Analysts weigh in

Fierce Pharma

Industry watchers largely breathed a sigh of relief last week after the Medicare price cuts for certain costly drugs under the Inflation Reduction Act initially appeared better than expected. | The magnitude of price cuts under the Inflation Reduction Act initially appeared better than expected. However, that rosy view may have missed an important point, one analyst team contends.

100
100
article thumbnail

Attorneys: Humana settles whistleblower suit for $90M

Fierce Healthcare

Humana has agreed to pay $90 million to settle a False Claims Act case related to its Medicare Part D contracts, according to the attorneys representing the whistleblower in the case. | Humana has agreed to pay $90 million to settle a False Claims Act case related to its Medicare Part D contracts, according to the attorneys representing the whistleblower in the case.

115
115
article thumbnail

Bavarian Nordic set to provide 12M doses of Jynneos to Africa amid current mpox outbreak

Fierce Pharma

With its rapid development of the Jynneos vaccine, Bavarian | After the WHO declared mpox a global health emergency for the second time in 25 months, Bavarian Nordic said it could ramp up manufacturing to supply 12 million doses of its Jynneos vaccine through 2025 to contain the virus in Africa.

article thumbnail

Medication Safety Quiz 2024

OctariusRx

The 2024 version of the OctariusRx medication safety quiz is about to be released. Ongoing education and assessments of staff medication management competency are standards of good practice. Medication competency and your consultant pharmacist are two things that should go hand-in-hand. How are you assessing your staff? Use our tool to help enhance patient safety and satisfy regulatory requirements.

article thumbnail

Does Medicaid cover Jardiance?

The Checkup by Singlecare

Jardiance (empagliflozin) is a brand-name prescription that helps adults with Type 2 diabetes manage their blood sugar levels. It can also lower the risk of death from heart disease and hospitalization for heart failure in adults whose hearts cannot pump enough blood to the rest of their body. Additionally, Jardiance can reduce the risk of worsening kidney disease, end-stage kidney disease (ESKD), death due to cardiovascular disease, and hospitalization in adults with chronic kidney disease.

article thumbnail

Health Care Costs, Financial Scams Top List of Health Concerns Among Older Adults

Drug Topics

Participants were asked to rate their level of concern on 26 health topics.

112
112
article thumbnail

Eli Lilly acquires Morphic in IBD portfolio expansion

Pharmaceutical Technology

Eli Lilly has concluded the acquisition of Morphic Holding at $57 per share, bolstering its inflammatory bowel disease portfolio.

105
105
article thumbnail

Safeguarding patient data: Four steps to consider when assessing your IT infrastructure

pharmaphorum

Safeguarding patient data is crucial in the healthcare industry. This article outlines four steps to consider when assessing your IT infrastructure to protect against ransomware and ensure the security of patient data.

73
article thumbnail

South African president calls on WHO for better mpox response

Pharmaceutical Technology

Cyril Ramaphosa, the president of South Africa, has asked the WHO to ensure African countries have equitable access to mpox vaccines.

article thumbnail

New First-Line Options Emerging for Type 2 Diabetes Care

Pharmacy Times

Glucagon-like peptide-1 receptor agonists and sodium-glucose contransporter-2 inhibitors have been added as first-line therapy recommendation for type 2 diabetes, the first since metformin

65
article thumbnail

Sound Pharmaceuticals plans to stick with WuXi amid BIOSECURE Act rumblings

Pharmaceutical Technology

Looking to potentially market their flagship drug SPI-1005, Sound CEO Jonathan Kil is keen to retain WuXi AppTec as a partner.

98
article thumbnail

Alaskans can virtually manage their diabetes risk for free with Omada

Fierce Healthcare

Virtual chronic care management company Omada is partnering with the state of Alaska to prevent and manage diabetes and hypertension. | Alaska is the biggest U.S. state, and much of it is rural. Many rural Alaskan towns lack in-person diabetes management support programs. The state department of health is subsidizing the cost of Omada's virtual diabetes and hypertension programs to fill the gap.

66
article thumbnail

Pfizer and BioNTech's COVID/flu vaccine hits a hurdle

pharmaphorum

Pfizer and BioNTech have a phase 3 mishap with their combined COVID-19 and influenza vaccine, handing Moderna an advantage